Content
1.
Please enter your name (this is required according to the Medicinal Products Act).
2.
Any mistakes you noticed (e.g. incorrect or misleading information, spelling)
3.
Any content you missed
4.
Most frequently read / most important content
Eligibility
Leukapheresis and Bridging
Lymphodepletion, CAR T-cell Transfusion and Monitoring
Toxicity
Follow up
Calculator
Literature
5.
Most frequently used (instant button)
Favorites
Calculator
Literature
Contact
6.
Specific content is easy to find.
Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree
7.
The content is clearly structured.
Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree
8.
The content is uptodate.
Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree
9.
The content is correct.
Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree
10.
The content is complete.
Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree
11.
The content improves the daily clinical practice.
Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree
12.
The chapters Eligibility, Leukapheresis, Bridging and CAR T cell transfusion...
Strongly agree
Agree
Neither agree or disagree
Disagree
Strongly disagree
... are comprehensively presented.
Strongly agree
Agree
Neither agree or disagree
Disagree
Strongly disagree
... include new information I did not know about of so far.
Strongly agree
Agree
Neither agree or disagree
Disagree
Strongly disagree
... facilitate the steps prior to the application of CARs and BiTEs.
Strongly agree
Agree
Neither agree or disagree
Disagree
Strongly disagree
13.
The toxicity chapter ...
Strongly agree
Agree
Neither agree or disagree
Disagree
Strongly disagree
... is comprehensively presented.
Strongly agree
Agree
Neither agree or disagree
Disagree
Strongly disagree
... includes new information I did not know about of so far.
Strongly agree
Agree
Neither agree or disagree
Disagree
Strongly disagree
... facilitates the toxicity management of CARs and BiTEs.
Strongly agree
Agree
Neither agree or disagree
Disagree
Strongly disagree
Current Progress,
0 of 38 answered